A COVID-19 infection apparently triggered the development of atypical hemolytic uremic syndrome (aHUS) in a 75-year-old man who had recently received a kidney transplant, according to a case report. Treatment with Ultomiris (ravulizumab) helped resolve his symptoms, supporting the use of the medication post-kidney transplant. Some kidney transplant…
Discussion
Living with multiple rare and chronic illnesses is stressful, difficult, and complicated. I have four autoimmune disorders and one connective tissue disorder, each of which comes with its own unique set of comorbidities. But the condition that causes the most issues for me is my primary illness, atypical hemolytic…
Becoming educated and informed about aHUS is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnist’s words of wisdom to help you along on your aHUS journey.
There is no cure for aHUS yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
